New Rili-BÄK limits for HbA1c - Interview with Dr. Knop-Hammad, Managing Director of Laboratory and Transfusion Medicine, Microbiology and Hospital Hygiene at BG Universitätsklinikum Bergmannsheil Bochum

The guideline of the German Medical Association for the quality assurance of laboratory medical examinations (Rili-BÄK) of October 18, 2019, has caused a great stir in the world of diagnostics. The guidelines for the HbA1c measurement parameter have been tightened considerably. Whereas coefficients of variation of ± 10 % were previously permitted, the specifications for internal quality assurance for HbA1c will be reduced to ± 3 % in December 2023 after what is now a four-year transition phase. An acceptance limit of ± 8 % already applies to the proficiency tests. This poses a challenge for many laboratories, practices and hospitals.

We talked to Dr. Knop-Hammad, Managing Director of Laboratory and Transfusion Medicine, Microbiology and Hospital Hygiene at BG Universitätsklinikum Bergmannsheil Bochum, about this. She told us how they met and overcame the challenge. In the interview, she tells us about the switch to the Adams™ HA-8180V from Arkray by the company Axonlab.

The interview is only available in German: click here